Impact of glucagon-like peptide 1 receptor agonists on lung function of diabetic patients: a 52 weeks clinical trial

P. Rogliani (Rome, Italy), L. Calzetta (Rome, Italy), A. Coppola (Rome, Italy), M. Cazzola (Rome, Italy), D. Lauro (Rome, Italy), M. Matera (Naples, Italy)

Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Session: Studies on the mechanisms underlying airway disease
Session type: Thematic Poster
Number: 4410
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Rogliani (Rome, Italy), L. Calzetta (Rome, Italy), A. Coppola (Rome, Italy), M. Cazzola (Rome, Italy), D. Lauro (Rome, Italy), M. Matera (Naples, Italy). Impact of glucagon-like peptide 1 receptor agonists on lung function of diabetic patients: a 52 weeks clinical trial. 4410

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: